Global and United States Nanostructured Drug Market Insights, Forecast to 2026

Global and United States Nanostructured Drug Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Nanostructured Drug Product Introduction
1.2 Market Segments
1.3 Key Nanostructured Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Nanostructured Drug Market Size Growth Rate by Type
1.4.2 Liposomes
1.4.3 Polymeric Micelles
1.4.4 Solid lipid Nanoparticles
1.4.5 Microemulsion and Nanoemulsion
1.4.6 Nanosuspension
1.5 Market by Application
1.5.1 Global Nanostructured Drug Market Size Growth Rate by Application
1.5.2 Cancer and Tumors
1.5.3 Autoimmune Disorders
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Nanostructured Drug Market Size, Estimates and Forecasts
2.1.1 Global Nanostructured Drug Revenue 2015-2026
2.1.2 Global Nanostructured Drug Sales 2015-2026
2.2 Global Nanostructured Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Nanostructured Drug Historical Market Size by Region (2015-2020)
2.3.1 Global Nanostructured Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Nanostructured Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Nanostructured Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Nanostructured Drug Sales Forecast by Region (2021-2026)
2.4.2 Global Nanostructured Drug Revenue Forecast by Region (2021-2026)
3 Global Nanostructured Drug Competitor Landscape by Players
3.1 Global Top Nanostructured Drug Sales by Manufacturers
3.1.1 Global Nanostructured Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Nanostructured Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global Nanostructured Drug Manufacturers by Revenue
3.2.1 Global Nanostructured Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Nanostructured Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Nanostructured Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Nanostructured Drug Revenue in 2019
3.2.5 Global Nanostructured Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Nanostructured Drug Price by Manufacturers
3.4 Global Nanostructured Drug Manufacturing Base Distribution, Product Types
3.4.1 Nanostructured Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Nanostructured Drug Product Type
3.4.3 Date of International Manufacturers Enter into Nanostructured Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Nanostructured Drug Market Size by Type (2015-2020)
4.1.1 Global Nanostructured Drug Sales by Type (2015-2020)
4.1.2 Global Nanostructured Drug Revenue by Type (2015-2020)
4.1.3 Nanostructured Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Nanostructured Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Nanostructured Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Nanostructured Drug Revenue Forecast by Type (2021-2026)
4.2.3 Nanostructured Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Nanostructured Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Nanostructured Drug Market Size by Application (2015-2020)
5.1.1 Global Nanostructured Drug Sales by Application (2015-2020)
5.1.2 Global Nanostructured Drug Revenue by Application (2015-2020)
5.1.3 Nanostructured Drug Price by Application (2015-2020)
5.2 Nanostructured Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Nanostructured Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Nanostructured Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Nanostructured Drug Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Nanostructured Drug Market Size YoY Growth 2015-2026
6.1.1 United States Nanostructured Drug Sales YoY Growth 2015-2026
6.1.2 United States Nanostructured Drug Revenue YoY Growth 2015-2026
6.1.3 United States Nanostructured Drug Market Share in Global Market 2015-2026
6.2 United States Nanostructured Drug Market Size by Players (International and Local Players)
6.2.1 United States Top Nanostructured Drug Players by Sales (2015-2020)
6.2.2 United States Top Nanostructured Drug Players by Revenue (2015-2020)
6.3 United States Nanostructured Drug Historic Market Review by Type (2015-2020)
6.3.1 United States Nanostructured Drug Sales Market Share by Type (2015-2020)
6.3.2 United States Nanostructured Drug Revenue Market Share by Type (2015-2020)
6.3.3 United States Nanostructured Drug Price by Type (2015-2020)
6.4 United States Nanostructured Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Nanostructured Drug Sales Forecast by Type (2021-2026)
6.4.2 United States Nanostructured Drug Revenue Forecast by Type (2021-2026)
6.4.3 United States Nanostructured Drug Price Forecast by Type (2021-2026)
6.5 United States Nanostructured Drug Historic Market Review by Application (2015-2020)
6.5.1 United States Nanostructured Drug Sales Market Share by Application (2015-2020)
6.5.2 United States Nanostructured Drug Revenue Market Share by Application (2015-2020)
6.5.3 United States Nanostructured Drug Price by Application (2015-2020)
6.6 United States Nanostructured Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Nanostructured Drug Sales Forecast by Application (2021-2026)
6.6.2 United States Nanostructured Drug Revenue Forecast by Application (2021-2026)
6.6.3 United States Nanostructured Drug Price Forecast by Application (2021-2026)
7 North America
7.1 North America Nanostructured Drug Market Size YoY Growth 2015-2026
7.2 North America Nanostructured Drug Market Facts & Figures by Country
7.2.1 North America Nanostructured Drug Sales by Country (2015-2020)
7.2.2 North America Nanostructured Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Nanostructured Drug Market Size YoY Growth 2015-2026
8.2 Europe Nanostructured Drug Market Facts & Figures by Country
8.2.1 Europe Nanostructured Drug Sales by Country
8.2.2 Europe Nanostructured Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Nanostructured Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific Nanostructured Drug Market Facts & Figures by Country
9.2.1 Asia Pacific Nanostructured Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific Nanostructured Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Nanostructured Drug Market Size YoY Growth 2015-2026
10.2 Latin America Nanostructured Drug Market Facts & Figures by Country
10.2.1 Latin America Nanostructured Drug Sales by Country
10.2.2 Latin America Nanostructured Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Nanostructured Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Nanostructured Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Nanostructured Drug Sales by Country
11.2.2 Middle East and Africa Nanostructured Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Merck
12.1.1 Merck Corporation Information
12.1.2 Merck Description and Business Overview
12.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Merck Nanostructured Drug Products Offered
12.1.5 Merck Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Description and Business Overview
12.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer Nanostructured Drug Products Offered
12.2.5 Pfizer Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Description and Business Overview
12.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novartis Nanostructured Drug Products Offered
12.3.5 Novartis Recent Development
12.4 Abbott
12.4.1 Abbott Corporation Information
12.4.2 Abbott Description and Business Overview
12.4.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Abbott Nanostructured Drug Products Offered
12.4.5 Abbott Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Corporation Information
12.5.2 GlaxoSmithKline Description and Business Overview
12.5.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.5.4 GlaxoSmithKline Nanostructured Drug Products Offered
12.5.5 GlaxoSmithKline Recent Development
12.6 Roche
12.6.1 Roche Corporation Information
12.6.2 Roche Description and Business Overview
12.6.3 Roche Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Roche Nanostructured Drug Products Offered
12.6.5 Roche Recent Development
12.7 Sanofi
12.7.1 Sanofi Corporation Information
12.7.2 Sanofi Description and Business Overview
12.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Sanofi Nanostructured Drug Products Offered
12.7.5 Sanofi Recent Development
12.8 Eli Lilly
12.8.1 Eli Lilly Corporation Information
12.8.2 Eli Lilly Description and Business Overview
12.8.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Eli Lilly Nanostructured Drug Products Offered
12.8.5 Eli Lilly Recent Development
12.9 Astrazeneca
12.9.1 Astrazeneca Corporation Information
12.9.2 Astrazeneca Description and Business Overview
12.9.3 Astrazeneca Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Astrazeneca Nanostructured Drug Products Offered
12.9.5 Astrazeneca Recent Development
12.10 Johnson & Johnson
12.10.1 Johnson & Johnson Corporation Information
12.10.2 Johnson & Johnson Description and Business Overview
12.10.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Johnson & Johnson Nanostructured Drug Products Offered
12.10.5 Johnson & Johnson Recent Development
12.11 Merck
12.11.1 Merck Corporation Information
12.11.2 Merck Description and Business Overview
12.11.3 Merck Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Merck Nanostructured Drug Products Offered
12.11.5 Merck Recent Development
12.12 Novavax
12.12.1 Novavax Corporation Information
12.12.2 Novavax Description and Business Overview
12.12.3 Novavax Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Novavax Products Offered
12.12.5 Novavax Recent Development
12.13 Stryker
12.13.1 Stryker Corporation Information
12.13.2 Stryker Description and Business Overview
12.13.3 Stryker Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Stryker Products Offered
12.13.5 Stryker Recent Development
12.14 Gilead Sciences
12.14.1 Gilead Sciences Corporation Information
12.14.2 Gilead Sciences Description and Business Overview
12.14.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Gilead Sciences Products Offered
12.14.5 Gilead Sciences Recent Development
12.15 OSI Pharmaceuticals
12.15.1 OSI Pharmaceuticals Corporation Information
12.15.2 OSI Pharmaceuticals Description and Business Overview
12.15.3 OSI Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.15.4 OSI Pharmaceuticals Products Offered
12.15.5 OSI Pharmaceuticals Recent Development
12.16 Kadmon Pharmaceuticals
12.16.1 Kadmon Pharmaceuticals Corporation Information
12.16.2 Kadmon Pharmaceuticals Description and Business Overview
12.16.3 Kadmon Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Kadmon Pharmaceuticals Products Offered
12.16.5 Kadmon Pharmaceuticals Recent Development
12.17 Samyang Biopharm
12.17.1 Samyang Biopharm Corporation Information
12.17.2 Samyang Biopharm Description and Business Overview
12.17.3 Samyang Biopharm Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Samyang Biopharm Products Offered
12.17.5 Samyang Biopharm Recent Development
12.18 Mitsubishi Pharma
12.18.1 Mitsubishi Pharma Corporation Information
12.18.2 Mitsubishi Pharma Description and Business Overview
12.18.3 Mitsubishi Pharma Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Mitsubishi Pharma Products Offered
12.18.5 Mitsubishi Pharma Recent Development
12.19 Kaken Pharmaceutical
12.19.1 Kaken Pharmaceutical Corporation Information
12.19.2 Kaken Pharmaceutical Description and Business Overview
12.19.3 Kaken Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Kaken Pharmaceutical Products Offered
12.19.5 Kaken Pharmaceutical Recent Development
12.20 Selecta Biosciences
12.20.1 Selecta Biosciences Corporation Information
12.20.2 Selecta Biosciences Description and Business Overview
12.20.3 Selecta Biosciences Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Selecta Biosciences Products Offered
12.20.5 Selecta Biosciences Recent Development
12.21 Par Pharmaceutical
12.21.1 Par Pharmaceutical Corporation Information
12.21.2 Par Pharmaceutical Description and Business Overview
12.21.3 Par Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Par Pharmaceutical Products Offered
12.21.5 Par Pharmaceutical Recent Development
12.22 Cerulean Pharma
12.22.1 Cerulean Pharma Corporation Information
12.22.2 Cerulean Pharma Description and Business Overview
12.22.3 Cerulean Pharma Sales, Revenue and Gross Margin (2015-2020)
12.22.4 Cerulean Pharma Products Offered
12.22.5 Cerulean Pharma Recent Development
12.23 Navidea Biopharmaceuticals
12.23.1 Navidea Biopharmaceuticals Corporation Information
12.23.2 Navidea Biopharmaceuticals Description and Business Overview
12.23.3 Navidea Biopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.23.4 Navidea Biopharmaceuticals Products Offered
12.23.5 Navidea Biopharmaceuticals Recent Development
12.24 Lummy
12.24.1 Lummy Corporation Information
12.24.2 Lummy Description and Business Overview
12.24.3 Lummy Sales, Revenue and Gross Margin (2015-2020)
12.24.4 Lummy Products Offered
12.24.5 Lummy Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Nanostructured Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Nanostructured Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Nanostructured Drug Market Segments
Table 2. Ranking of Global Top Nanostructured Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Nanostructured Drug Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Liposomes
Table 5. Major Manufacturers of Polymeric Micelles
Table 6. Major Manufacturers of Solid lipid Nanoparticles
Table 7. Major Manufacturers of Microemulsion and Nanoemulsion
Table 8. Major Manufacturers of Nanosuspension
Table 9. Global Nanostructured Drug Market Size Growth Rate by Application 2020-2026 (K MT)
Table 10. Global Nanostructured Drug Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 11. Global Nanostructured Drug Sales by Regions 2015-2020 (K MT)
Table 12. Global Nanostructured Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Nanostructured Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Nanostructured Drug Sales Forecast by Region (2021-2026) (K MT)
Table 15. Global Nanostructured Drug Sales by Manufacturers (2015-2020) (K MT)
Table 16. Global Nanostructured Drug Sales Share by Manufacturers (2015-2020)
Table 17. Global Nanostructured Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Nanostructured Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanostructured Drug as of 2019)
Table 19. Nanostructured Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Nanostructured Drug Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Nanostructured Drug Price (2015-2020) (USD/MT)
Table 22. Nanostructured Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Nanostructured Drug Product Type
Table 24. Date of International Manufacturers Enter into Nanostructured Drug Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Nanostructured Drug Sales by Type (2015-2020) (K MT)
Table 27. Global Nanostructured Drug Sales Share by Type (2015-2020)
Table 28. Global Nanostructured Drug Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Nanostructured Drug Revenue Share by Type (2015-2020)
Table 30. Nanostructured Drug Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 31. Global Nanostructured Drug Sales Share by Type (2021-2026)
Table 32. Global Nanostructured Drug Sales by Application (2015-2020) (K MT)
Table 33. Global Nanostructured Drug Sales Share by Application (2015-2020)
Table 34. Global Nanostructured Drug Sales Share by Application (2021-2026)
Table 35. Global Nanostructured Drug Sales Market Share Forecast by Application (2021-2026)
Table 36. Global Nanostructured Drug Revenue by Application (2015-2020) (US$ Million)
Table 37. Global Nanostructured Drug Revenue Market Share Forecast by Application (2021-2026)
Table 38. United States Nanostructured Drug Sales (K MT) of Key Companies (2015-2020)
Table 39. United States Nanostructured Drug Sales Share by Company (2015-2020)
Table 40. United States Nanostructured Drug Revenue (US$ Million) by Company (2015-2020)
Table 41. United States Nanostructured Drug Sales (K MT) by Type (2015-2020)
Table 42. United States Nanostructured Drug Sales Share by Type (2015-2020)
Table 43. United States Nanostructured Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 44. United States Nanostructured Drug Price (K MT) by Type (2015-2020)
Table 45. United States Nanostructured Drug Sales (K MT) by Type (2021-2026)
Table 46. United States Nanostructured Drug Sales Share by Type (2021-2026)
Table 47. United States Nanostructured Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 48. United States Nanostructured Drug Revenue Share by Type (2021-2026)
Table 49. United States Nanostructured Drug Price (K MT) by Type (2021-2026)
Table 50. United States Nanostructured Drug Sales (K MT) by Application (2015-2020)
Table 51. United States Nanostructured Drug Sales Share by Application (2015-2020)
Table 52. United States Nanostructured Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 53. United States Nanostructured Drug Sales (K MT) by Application (2021-2026)
Table 54. United States Nanostructured Drug Sales Share by Application (2021-2026)
Table 55. United States Nanostructured Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 56. United States Nanostructured Drug Revenue Share by Application (2021-2026)
Table 57. North America Nanostructured Drug Sales by Country (2015-2020) (K MT)
Table 58. North America Nanostructured Drug Sales Market Share by Country (2015-2020)
Table 59. North America Nanostructured Drug Revenue by Country (2015-2020) (US$ Million)
Table 60. North America Nanostructured Drug Revenue Market Share by Country (2015-2020)
Table 61. Europe Nanostructured Drug Sales by Country (2015-2020) (K MT)
Table 62. Europe Nanostructured Drug Sales Market Share by Country (2015-2020)
Table 63. Europe Nanostructured Drug Revenue by Country (2015-2020) (US$ Million)
Table 64. Europe Nanostructured Drug Revenue Market Share by Country (2015-2020)
Table 65. Asia Pacific Nanostructured Drug Sales by Region (2015-2020) (K MT)
Table 66. Asia Pacific Nanostructured Drug Sales Market Share by Region (2015-2020)
Table 67. Asia Pacific Nanostructured Drug Revenue by Region (2015-2020) (US$ Million)
Table 68. Asia Pacific Nanostructured Drug Revenue Market Share by Region (2015-2020)
Table 69. Latin America Nanostructured Drug Sales by Country (2015-2020) (K MT)
Table 70. Latin America Nanostructured Drug Sales Market Share by Country (2015-2020)
Table 71. Latin Americaa Nanostructured Drug Revenue by Country (2015-2020) (US$ Million)
Table 72. Latin America Nanostructured Drug Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Nanostructured Drug Sales by Country (2015-2020) (K MT)
Table 74. Middle East and Africa Nanostructured Drug Sales Market Share by Country (2015-2020)
Table 75. Middle East and Africa Nanostructured Drug Revenue by Country (2015-2020) (US$ Million)
Table 76. Middle East and Africa Nanostructured Drug Revenue Market Share by Country (2015-2020)
Table 77. Merck Corporation Information
Table 78. Merck Description and Business Overview
Table 79. Merck Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 80. Merck Nanostructured Drug Product
Table 81. Merck Recent Development
Table 82. Pfizer Corporation Information
Table 83. Pfizer Description and Business Overview
Table 84. Pfizer Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 85. Pfizer Product
Table 86. Pfizer Recent Development
Table 87. Novartis Corporation Information
Table 88. Novartis Description and Business Overview
Table 89. Novartis Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 90. Novartis Product
Table 91. Novartis Recent Development
Table 92. Abbott Corporation Information
Table 93. Abbott Description and Business Overview
Table 94. Abbott Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 95. Abbott Product
Table 96. Abbott Recent Development
Table 97. GlaxoSmithKline Corporation Information
Table 98. GlaxoSmithKline Description and Business Overview
Table 99. GlaxoSmithKline Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 100. GlaxoSmithKline Product
Table 101. GlaxoSmithKline Recent Development
Table 102. Roche Corporation Information
Table 103. Roche Description and Business Overview
Table 104. Roche Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 105. Roche Product
Table 106. Roche Recent Development
Table 107. Sanofi Corporation Information
Table 108. Sanofi Description and Business Overview
Table 109. Sanofi Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 110. Sanofi Product
Table 111. Sanofi Recent Development
Table 112. Eli Lilly Corporation Information
Table 113. Eli Lilly Description and Business Overview
Table 114. Eli Lilly Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 115. Eli Lilly Product
Table 116. Eli Lilly Recent Development
Table 117. Astrazeneca Corporation Information
Table 118. Astrazeneca Description and Business Overview
Table 119. Astrazeneca Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 120. Astrazeneca Product
Table 121. Astrazeneca Recent Development
Table 122. Johnson & Johnson Corporation Information
Table 123. Johnson & Johnson Description and Business Overview
Table 124. Johnson & Johnson Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 125. Johnson & Johnson Product
Table 126. Johnson & Johnson Recent Development
Table 127. Celgene Corporation Information
Table 128. Celgene Description and Business Overview
Table 129. Celgene Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 130. Celgene Product
Table 131. Celgene Recent Development
Table 132. Novavax Corporation Information
Table 133. Novavax Description and Business Overview
Table 134. Novavax Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 135. Novavax Product
Table 136. Novavax Recent Development
Table 137. Stryker Corporation Information
Table 138. Stryker Description and Business Overview
Table 139. Stryker Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 140. Stryker Product
Table 141. Stryker Recent Development
Table 142. Gilead Sciences Corporation Information
Table 143. Gilead Sciences Description and Business Overview
Table 144. Gilead Sciences Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 145. Gilead Sciences Product
Table 146. Gilead Sciences Recent Development
Table 147. OSI Pharmaceuticals Corporation Information
Table 148. OSI Pharmaceuticals Description and Business Overview
Table 149. OSI Pharmaceuticals Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 150. OSI Pharmaceuticals Product
Table 151. OSI Pharmaceuticals Recent Development
Table 152. Kadmon Pharmaceuticals Corporation Information
Table 153. Kadmon Pharmaceuticals Description and Business Overview
Table 154. Kadmon Pharmaceuticals Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 155. Kadmon Pharmaceuticals Product
Table 156. Kadmon Pharmaceuticals Recent Development
Table 157. Samyang Biopharm Corporation Information
Table 158. Samyang Biopharm Description and Business Overview
Table 159. Samyang Biopharm Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 160. Samyang Biopharm Product
Table 161. Samyang Biopharm Recent Development
Table 162. Mitsubishi Pharma Corporation Information
Table 163. Mitsubishi Pharma Description and Business Overview
Table 164. Mitsubishi Pharma Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 165. Mitsubishi Pharma Product
Table 166. Mitsubishi Pharma Recent Development
Table 167. Kaken Pharmaceutical Corporation Information
Table 168. Kaken Pharmaceutical Description and Business Overview
Table 169. Kaken Pharmaceutical Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 170. Kaken Pharmaceutical Product
Table 171. Kaken Pharmaceutical Recent Development
Table 172. Selecta Biosciences Corporation Information
Table 173. Selecta Biosciences Description and Business Overview
Table 174. Selecta Biosciences Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 175. Selecta Biosciences Product
Table 176. Selecta Biosciences Recent Development
Table 177. Par Pharmaceutical Corporation Information
Table 178. Par Pharmaceutical Description and Business Overview
Table 179. Par Pharmaceutical Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 180. Par Pharmaceutical Product
Table 181. Par Pharmaceutical Recent Development
Table 182. Cerulean Pharma Corporation Information
Table 183. Cerulean Pharma Description and Business Overview
Table 184. Cerulean Pharma Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 185. Cerulean Pharma Product
Table 186. Cerulean Pharma Recent Development
Table 187. Navidea Biopharmaceuticals Corporation Information
Table 188. Navidea Biopharmaceuticals Description and Business Overview
Table 189. Navidea Biopharmaceuticals Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 190. Navidea Biopharmaceuticals Product
Table 191. Navidea Biopharmaceuticals Recent Development
Table 192. Lummy Corporation Information
Table 193. Lummy Description and Business Overview
Table 194. Lummy Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 195. Lummy Product
Table 196. Lummy Recent Development
Table 197. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 198. Key Challenges
Table 199. Market Risks
Table 200. Main Points Interviewed from Key Nanostructured Drug Players
Table 201. Nanostructured Drug Customers List
Table 202. Nanostructured Drug Distributors List
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
List of Figures
Figure 1. Nanostructured Drug Product Picture
Figure 2. Global Nanostructured Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Liposomes Product Picture
Figure 4. Polymeric Micelles Product Picture
Figure 5. Solid lipid Nanoparticles Product Picture
Figure 6. Microemulsion and Nanoemulsion Product Picture
Figure 7. Nanosuspension Product Picture
Figure 8. Global Nanostructured Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Cancer and Tumors
Figure 10. Autoimmune Disorders
Figure 11. Nanostructured Drug Report Years Considered
Figure 12. Global Nanostructured Drug Market Size 2015-2026 (US$ Million)
Figure 13. Global Nanostructured Drug Sales 2015-2026 (K MT)
Figure 14. Global Nanostructured Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Nanostructured Drug Sales Market Share by Region (2015-2020)
Figure 16. Global Nanostructured Drug Sales Market Share by Region in 2019
Figure 17. Global Nanostructured Drug Revenue Market Share by Region (2015-2020)
Figure 18. Global Nanostructured Drug Revenue Market Share by Region in 2019
Figure 19. Global Nanostructured Drug Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Nanostructured Drug Revenue in 2019
Figure 21. Nanostructured Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Nanostructured Drug Sales Market Share by Type (2015-2020)
Figure 23. Global Nanostructured Drug Sales Market Share by Type in 2019
Figure 24. Global Nanostructured Drug Revenue Market Share by Type (2015-2020)
Figure 25. Global Nanostructured Drug Revenue Market Share by Type in 2019
Figure 26. Global Nanostructured Drug Market Share by Price Range (2015-2020)
Figure 27. Global Nanostructured Drug Sales Market Share by Application (2015-2020)
Figure 28. Global Nanostructured Drug Sales Market Share by Application in 2019
Figure 29. Global Nanostructured Drug Revenue Market Share by Application (2015-2020)
Figure 30. Global Nanostructured Drug Revenue Market Share by Application in 2019
Figure 31. United States Nanostructured Drug Sales Growth Rate 2015-2026 (K MT)
Figure 32. United States Nanostructured Drug Revenue Growth Rate 2015-2026 (US$ Million)
Figure 33. United States Nanostructured Drug Market Share in Global Market 2015-2026
Figure 34. United States 5 and 10 Largest Nanostructured Drug Players Market Share by Revenue in Nanostructured Drug in 2019
Figure 35. United States Nanostructured Drug Revenue Share by Type (2015-2020)
Figure 36. United States Nanostructured D

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs